TipRanks on MSN
Pfizer’s Phase 3 Study on PF-06823859: A Potential Game-Changer for Myositis Treatment
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 3 clinical study titled A PHASE 3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback